Verma BK, Kondaiah P

IGFBP2 is one of the highly expressed genes in glioblastoma (GBM). It has both IGF dependent and independent activities. IGF independent actions are mediated by the activation of integrin signalling through its RGD motif present at C-terminal domain. One of the actions of IGFBP2 is to regulate ?-catenin by the ...

Read More

inactivation of GSK3?, which preferentially accumulates in the cytoplasm. The mechanism of nuclear ?-catenin regulation by IGFBP2 and role of cytoplasmic ?-catenin is not clear. We aimed to understand the mechanism in GBM cell lines.The gene expression studies were performed by RT-PCR, western blot analysis; the knockdown of genes was performed by shRNA transfection; RNAIP and luciferase reporter assays were utilized to study the cytoplasmic regulation of genes by ?-catenin; neurosphere assays were performed to study the stemness of cells.IGFBP2 overexpression or treatment in GBM cells regulates ?-catenin, TRIM33 (E3 ubiquitin ligase) and Oct4 genes. TRIM33 was induced by IGFBP2. ?-catenin was found to accumulate predominantly in the cytoplasm and nuclear ?-catenin was depleted by IGFBP2 induced TRIM33. IGFBP2 regulated cytoplasmic ?-catenin binds to 3' UTR of Oct4 RNA. IGFBP2 was also able to induce stemness of glioma cells.IGFBP2 induces TRIM33 which regulates the nuclear ?-catenin protein. In addition, IGFBP2 stabilizes the cytoplasmic ?-catenin which is involved in the regulation of Oct4 transcript and consequently induction of stemness of glioma cells.

Date: Sep. 01, 2020

View in: Pubmed Google Scholar

229100